DE69122364D1 - Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen - Google Patents

Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen

Info

Publication number
DE69122364D1
DE69122364D1 DE69122364T DE69122364T DE69122364D1 DE 69122364 D1 DE69122364 D1 DE 69122364D1 DE 69122364 T DE69122364 T DE 69122364T DE 69122364 T DE69122364 T DE 69122364T DE 69122364 D1 DE69122364 D1 DE 69122364D1
Authority
DE
Germany
Prior art keywords
anesthesia
desflurane
isoflurane
well
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69122364T
Other languages
English (en)
Other versions
DE69122364T2 (de
Inventor
James W Young
Steven Brandt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of DE69122364D1 publication Critical patent/DE69122364D1/de
Application granted granted Critical
Publication of DE69122364T2 publication Critical patent/DE69122364T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69122364T 1990-11-29 1991-11-22 Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen Expired - Fee Related DE69122364T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/619,780 US5114715A (en) 1990-11-29 1990-11-29 Methods of use and compositions of (s)-isoflurane and (s)-desflurane

Publications (2)

Publication Number Publication Date
DE69122364D1 true DE69122364D1 (de) 1996-10-31
DE69122364T2 DE69122364T2 (de) 1997-03-13

Family

ID=24483269

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69122364T Expired - Fee Related DE69122364T2 (de) 1990-11-29 1991-11-22 Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen

Country Status (5)

Country Link
US (1) US5114715A (de)
EP (1) EP0491586B1 (de)
JP (1) JPH05186339A (de)
AT (1) ATE143260T1 (de)
DE (1) DE69122364T2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283372A (en) * 1991-12-04 1994-02-01 Anaquest, Inc. Preparation of purified optical isomers of desflurane
US5331000A (en) * 1992-03-09 1994-07-19 Sepracor Inc. Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
EP1145715A3 (de) * 1992-07-07 2004-05-19 Sepracor Inc. Verfahren zur Verwendung von (-) Cisapride zur Behandlung von Magenspeiseroehrenruechstornung und anderen Erkrankungen
CA2139636A1 (en) * 1992-07-07 1994-01-20 Nancy M. Gray Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
JPH08502981A (ja) * 1992-11-04 1996-04-02 セプラコア，インコーポレイテッド 高血圧の治療のための方法および（＋）ドキサゾシンの組成物
US5443824A (en) * 1994-03-14 1995-08-22 Piacquadio; Daniel J. Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions
GB9418532D0 (en) * 1994-09-14 1994-11-02 Univ Aberdeen Anaesthetic gas mixtures
US5739151A (en) * 1996-07-19 1998-04-14 Sepracor Inc. Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride
US20030200963A1 (en) * 1998-01-09 2003-10-30 Flament-Garcia Mary Jane Container for an inhalation anesthetic
US6074668A (en) * 1998-01-09 2000-06-13 Abbott Laboratories Container for an inhalation anesthetic
US6083514A (en) * 1998-01-09 2000-07-04 Abbott Laboratories Polymethylpentene container for an inhalation anesthetic
US6162443A (en) 1998-01-09 2000-12-19 Abbott Laboratories Container for an inhalation anesthetic
NZ555173A (en) * 2004-11-17 2010-04-30 Piramal Critical Care Inc Process for producing desflurane from isoflurane with antimony pentafluoride and HF
JP2010504359A (ja) * 2006-09-20 2010-02-12 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 局部麻酔および／または疼痛緩和のための、揮発性麻酔剤を送達するための方法
CA2712516C (en) 2008-01-22 2016-06-28 Vapogenix, Inc. Volatile anesthetic compositions and methods of use
WO2010129686A1 (en) 2009-05-05 2010-11-11 Vapogenix, Inc. Novel formulations of volatile anesthetics and methods of use for reducing inflammation
JP4991834B2 (ja) * 2009-12-17 2012-08-01 シャープ株式会社 車両用前照灯
CN103764128A (zh) 2011-06-24 2014-04-30 维普詹尼克斯公司 用于治疗皮肤病症或疾病的新型制剂和方法
CN113712911A (zh) 2013-03-15 2021-11-30 维普詹尼克斯公司 新型镇痛组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3469011A (en) * 1966-10-03 1969-09-23 Air Reduction 1,1,2-trifluoro-2-chloroethyl-difluoromethyl ether as an anesthetic agent
US3535388A (en) * 1969-05-12 1970-10-20 Air Reduction 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether
US3897502A (en) * 1971-10-22 1975-07-29 Airco Inc Process for making fluorinated ethers
DE2340560C2 (de) * 1973-08-10 1982-12-16 Hoechst Ag, 6000 Frankfurt 1.2.2.2-Tetrafluoräthyl-äther, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltendes Inhalations-Anästhetikum
DE2340561C2 (de) * 1973-08-10 1982-12-16 Hoechst Ag, 6000 Frankfurt 2.2.2-Trifluor-1-chloräthyl-äther und Verfahren zu ihrer Herstellung sowie Inhalations-Anästhetikum, das einen dieser Stoffe enthält
US3970710A (en) * 1975-04-09 1976-07-20 Abbott Laboratories Process for making trifluoroethanol
DE2656545A1 (de) * 1976-12-14 1978-06-15 Hoechst Ag Polyhalogenierte alpha, alpha'-difluordialkylaether und verfahren zu ihrer herstellung
US4220664A (en) * 1979-01-29 1980-09-02 The Dow Chemical Company Deuterated isoflurane as an anesthetic agent
US4273947A (en) * 1979-01-31 1981-06-16 Allied Chemical Corporation Hydrogenation of fluorine-containing carboxylic acids
US4262144A (en) * 1979-10-25 1981-04-14 The Dow Chemical Company Deuterated isoflurane
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
US4590310A (en) * 1984-08-02 1986-05-20 The Boc Group, Inc. Process for the preparation of 2,2,2-trifluoroethanol
US4762856A (en) * 1987-02-02 1988-08-09 Boc, Inc. Anesthetic composition and method of using the same
US4855511A (en) * 1988-07-18 1989-08-08 Boc, Inc. Process for preparing CHF2 OCHFCF3 and CHF2 OCHClCF3 and novel intermediate compounds employed therein

Also Published As

Publication number Publication date
EP0491586A1 (de) 1992-06-24
JPH05186339A (ja) 1993-07-27
US5114715A (en) 1992-05-19
EP0491586B1 (de) 1996-09-25
DE69122364T2 (de) 1997-03-13
ATE143260T1 (de) 1996-10-15

Similar Documents

Publication Publication Date Title
DE69122364T2 (de) Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE3855113T2 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE297726T1 (de) Forskolin zur entwicklung magerer körpermasse
SE8102193L (sv) Terapeutiskt aktiv organisk forening och dess anvendning
ATE111733T1 (de) Verwendung von nikotin zur herstellung eines kit zur behandlung von krankheitszuständen, die auf eine nikotinbehandlung ansprechen.
DK1201241T3 (da) Sammensætninger indeholdende capsaicin eller capsaicinanaloge og et bedøvelsesmiddel
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE59109222D1 (de) Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen
ATE25525T1 (de) N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr.
DE69121561D1 (de) Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht
DE69214467T3 (de) Verwendung von L-2-oxo Thiazolidin-4-carboxylat zur Behandlung von Atemnotsyndrom
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE3850154T2 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
ATE307203T1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
DE69333412D1 (de) Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie
DE3781488T2 (de) Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'-didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
DE69420679D1 (de) Verwendung der 1-4-4-Aryl(oder Heteroaryl)-1-Piperazinylbutyl-1H-Azol-Derivate zur Herstellung von Arzneimitteln zur Behandlung der Störungen der Magensekretion
ATE108658T1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
ATE232387T1 (de) Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes
DE58904337D1 (de) Arzneimittel enthaltend nitroxyalkylamine mit amidfunktion und verfahren zur herstellung dieser verbindungen.
DK59281A (da) Fremgangsmaade til fremstilling af phenylpiperazinderivater af 1,3,4-oxadiazolylphenolder
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee